Teladoc Health (TDOC) Cash from Investing Activities (2014 - 2026)

Teladoc Health has disclosed Cash from Investing Activities across 13 years of filings, most recently posting -$36.5 million for Q1 2026.

• Cash from Investing Activities for Q1 2026 came in at -$36.5 million, up 70.37% year-over-year; the trailing twelve-month figure through Mar 2026 was -$179.3 million (up 15.37% YoY), and the FY2025 annual result was -$266.0 million, down 114.43% from the prior year.
• Cash from Investing Activities came in at -$36.5 million for Q1 2026 at Teladoc Health, down from -$34.3 million in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of -$27.6 million in Q1 2022 to a low of -$123.3 million in Q1 2025.
• The 5-year median for Cash from Investing Activities is -$36.6 million (2023), against an average of -$44.2 million.
• Across the five-year window, Cash from Investing Activities tumbled 1968.13% in 2022 and surged 70.37% in 2026, its largest moves.
• Teladoc Health's Cash from Investing Activities stood at -$53.9 million in 2022, then surged by 32.26% to -$36.5 million in 2023, then gained by 18.8% to -$29.6 million in 2024, then retreated by 15.77% to -$34.3 million in 2025, then decreased by 6.42% to -$36.5 million in 2026.
• The last three Cash from Investing Activities figures came in at -$36.5 million (Q1 2026), -$34.3 million (Q4 2025), and -$48.7 million (Q3 2025), per Business Quant data.